SLC11A2
Basic information
Region (hg38): 12:50979401-51028566
Previous symbols: [ "NRAMP2" ]
Links
Phenotypes
GenCC
Source:
- microcytic anemia with liver iron overload (Strong), mode of inheritance: AR
- microcytic anemia with liver iron overload (Supportive), mode of inheritance: AR
- microcytic anemia with liver iron overload (Moderate), mode of inheritance: AR
- microcytic anemia with liver iron overload (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Anemia, hypochromic microcytic, with iron overload | AR | Hematologic | Individuals can require RBC transfusions and erythropoietin treatment; As hepatic iron overload is common, awareness may allow monitoring and adjustment of treatments and surveillance accordingly | Hematologic | 14135503; 15459009; 16439678; 16160008; 16584902; 21871825; 22313374 |
ClinVar
This is a list of variants' phenotypes submitted to
- Microcytic anemia with liver iron overload (2 variants)
- SLC11A2-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC11A2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | |||||
missense | 32 | 40 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 6 | 3 | 2 | 11 | ||
non coding | 36 | 17 | 60 | |||
Total | 2 | 1 | 75 | 14 | 23 |
Variants in SLC11A2
This is a list of pathogenic ClinVar variants found in the SLC11A2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-50985993-T-A | Microcytic anemia with liver iron overload | Uncertain significance (Jan 13, 2018) | ||
12-50986004-AT-A | Microcytic anemia with liver iron overload | Uncertain significance (Jun 14, 2016) | ||
12-50986036-C-A | Microcytic anemia with liver iron overload | Uncertain significance (Jan 12, 2018) | ||
12-50986240-ACT-A | Microcytic anemia with liver iron overload | Uncertain significance (Jun 14, 2016) | ||
12-50986376-T-C | Microcytic anemia with liver iron overload | Uncertain significance (Jan 13, 2018) | ||
12-50986423-G-C | Microcytic anemia with liver iron overload | Uncertain significance (Jan 13, 2018) | ||
12-50986449-A-G | Microcytic anemia with liver iron overload | Benign (Jan 13, 2018) | ||
12-50986530-C-T | Microcytic anemia with liver iron overload | Uncertain significance (Jan 13, 2018) | ||
12-50986572-A-AT | Microcytic anemia with liver iron overload | Uncertain significance (Jun 14, 2016) | ||
12-50986586-G-A | Microcytic anemia with liver iron overload | Uncertain significance (Jan 13, 2018) | ||
12-50986710-A-G | Microcytic anemia with liver iron overload | Uncertain significance (Jan 12, 2018) | ||
12-50986726-G-A | Microcytic anemia with liver iron overload | Uncertain significance (Jan 13, 2018) | ||
12-50986766-C-A | Microcytic anemia with liver iron overload | Uncertain significance (Jan 13, 2018) | ||
12-50986839-C-A | Microcytic anemia with liver iron overload | Benign (Jan 12, 2018) | ||
12-50986858-C-CA | Microcytic anemia with liver iron overload | Uncertain significance (Jun 14, 2016) | ||
12-50986881-G-A | Microcytic anemia with liver iron overload | Uncertain significance (Jan 12, 2018) | ||
12-50986958-A-G | Microcytic anemia with liver iron overload | Uncertain significance (Jan 13, 2018) | ||
12-50986965-T-C | Microcytic anemia with liver iron overload | Uncertain significance (Jan 13, 2018) | ||
12-50987052-C-T | Microcytic anemia with liver iron overload | Benign (Jan 13, 2018) | ||
12-50987064-C-T | Microcytic anemia with liver iron overload | Benign (Jan 13, 2018) | ||
12-50987110-T-G | Microcytic anemia with liver iron overload | Benign (Jan 13, 2018) | ||
12-50987267-C-T | Microcytic anemia with liver iron overload | Uncertain significance (Jan 13, 2018) | ||
12-50987268-G-A | Microcytic anemia with liver iron overload | Uncertain significance (Jan 13, 2018) | ||
12-50987294-C-T | Microcytic anemia with liver iron overload | Benign (Jan 13, 2018) | ||
12-50987318-T-C | Microcytic anemia with liver iron overload | Uncertain significance (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC11A2 | protein_coding | protein_coding | ENST00000394904 | 16 | 49166 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00665 | 0.993 | 125722 | 0 | 25 | 125747 | 0.0000994 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.23 | 213 | 326 | 0.653 | 0.0000174 | 3806 |
Missense in Polyphen | 46 | 106.96 | 0.43007 | 1240 | ||
Synonymous | -0.0107 | 119 | 119 | 1.00 | 0.00000615 | 1206 |
Loss of Function | 3.63 | 10 | 32.3 | 0.310 | 0.00000163 | 371 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000124 | 0.000123 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000159 | 0.000158 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000133 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Important in metal transport, in particular iron. Can also transport manganese, cobalt, cadmium, nickel, vanadium and lead. Involved in apical iron uptake into duodenal enterocytes. Involved in iron transport from acidified endosomes into the cytoplasm of erythroid precursor cells. May play an important role in hepatic iron accumulation and tissue iron distribution. May serve to import iron into the mitochondria. {ECO:0000269|PubMed:17109629, ECO:0000269|PubMed:24448823, ECO:0000269|PubMed:25326704, ECO:0000269|PubMed:25491917}.;
- Disease
- DISEASE: Anemia, hypochromic microcytic, with iron overload 1 (AHMIO1) [MIM:206100]: A hematologic disease characterized by abnormal hemoglobin content in the erythrocytes which are reduced in size. The disorder is due to an error of iron metabolism that results in high serum iron, massive hepatic iron deposition, and absence of sideroblasts and stainable bone marrow iron store. Despite adequate transferrin-iron complex, delivery of iron to the erythroid bone marrow is apparently insufficient for the demands of hemoglobin synthesis. {ECO:0000269|PubMed:15459009, ECO:0000269|PubMed:16160008, ECO:0000269|PubMed:16439678}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Lysosome - Homo sapiens (human);Mineral absorption - Homo sapiens (human);Ferroptosis - Homo sapiens (human);Iron metabolism in placenta;Copper homeostasis;Hereditary Leiomyomatosis and Renal Cell Carcinoma Pathway;HIF-2-alpha transcription factor network;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Transport of small molecules;Metal ion SLC transporters;Iron uptake and transport
(Consensus)
Recessive Scores
- pRec
- 0.382
Intolerance Scores
- loftool
- 0.697
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.6
Haploinsufficiency Scores
- pHI
- 0.557
- hipred
- Y
- hipred_score
- 0.696
- ghis
- 0.466
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.795
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc11a2
- Phenotype
- liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; cellular phenotype; immune system phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- slc11a2
- Affected structure
- erythroid lineage cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- response to hypoxia;heme biosynthetic process;cobalt ion transport;copper ion transport;iron ion transport;manganese ion transport;cellular iron ion homeostasis;learning or memory;response to iron ion;lead ion transport;iron import into cell;iron ion transmembrane transport;copper ion transmembrane transport;nickel cation transmembrane transport;dendrite morphogenesis;erythrocyte development;multicellular organismal iron ion homeostasis;cadmium ion transmembrane transport;manganese ion transmembrane transport;proton transmembrane transport
- Cellular component
- nucleus;cytoplasm;mitochondrion;mitochondrial outer membrane;lysosomal membrane;early endosome;vacuole;plasma membrane;integral component of plasma membrane;cell surface;membrane;apical plasma membrane;cytoplasmic vesicle;brush border membrane;late endosome membrane;apical part of cell;basal part of cell;perinuclear region of cytoplasm;recycling endosome;paraferritin complex;extracellular vesicle
- Molecular function
- copper ion transmembrane transporter activity;iron ion transmembrane transporter activity;manganese ion transmembrane transporter activity;iron ion binding;copper ion binding;protein binding;zinc ion binding;cadmium ion transmembrane transporter activity;cobalt ion transmembrane transporter activity;ferrous iron transmembrane transporter activity;lead ion transmembrane transporter activity;nickel cation transmembrane transporter activity;solute:proton symporter activity;nickel cation binding;manganese ion binding;cadmium ion binding;transition metal ion transmembrane transporter activity;cobalt ion binding